BUY Shriram Finance Limited — Kshitija Salvi, Globe Capital Market
byKshitija Salvi, Globe Capital MarketHorizon: NA (inferred Swing (≤2wk))3 Aug 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
3 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days
Advisor consensus · adjacent horizon·13 Aug · yesterday
7 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days
Advisor consensus · same horizon·13 Aug · yesterday
Shriram Finance maintains higher highs, trades above key moving averages: Ajit Mishra
NewsEt-Markets·11 Aug · 3d ago
Shriram Finance's Triple Growth Story Keeps Nirmal Bang Bullish After Q1 — Check Target Price
NewsNdtv-Profit·27 Jul · 3w ago
Shriram Finance's Earnings Shine, Yet Analysts See One Hurdle Before A Bigger Re-Rating
NewsNdtv-Profit·27 Jul · 3w ago
Mirae Asset Sharekhan: இந்த 3 பங்குகள் ஏற்றம் காணும் - டெக்னிக்கல் ஆய்வில் தகவல்!
NewsGoogle News·14 Aug · today
Mirae Asset Sharekhan Names 3 Large-Cap Stocks With Technical Upside Potential
NewsGoogle News·14 Aug · today
Nifty Holds 24,350 Support; Indian Bank, PB Fintech, Shriram Finance Show Momentum
NewsGoogle News·13 Aug · yesterday
Foreign borrowings hit over $6 billion in June as 140 firms tap global market
NewsEt-Markets·6 Aug · 1w ago
Q1 Results Today Highlights: Tata Consumer con. PAT up 28.4%, ACC PAT declines 61.5%, Shriram Finance, Hindustan Zinc, SBI Life, SBI Cards, Laurus Labs Q1 profit rise
NewsHbl·24 Jul · 3w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Shriram Finance
- BUY — Neeraj Dewan15 Oct 2026 · ~1 year · target ₹1,050 · Active
- BUY — Aastha Jain, Hem Securities14 Oct 2026 · ~2 weeks · target ₹1,030 · SL hit
- BUY — Kush Bohra13 Oct 2026 · ~2 weeks · target ₹1,000 · Active
- BUY — Sumeet Bagadia, Choice Broking6 Oct 2026 · Same day · target ₹995 · Expired
- BUY — Vikas Salunkhe, Nirmal Bang Securities30 Sept 2026 · Same day · target ₹1,010 · Expired
More from Kshitija Salvi, Globe Capital Market
- BUY Laurus Labs11 Sept 2026 · ~2 weeks · target ₹2,140 · SL hit
- BUY Ather Energy10 Sept 2026 · ~2 weeks · target ₹1,760 · SL hit
- BUY Cholamandalam Investment and Finance Company10 Sept 2026 · ~2 weeks · target ₹1,985 · SL hit
- BUY Adani Ports and Special Economic Zone9 Sept 2026 · ~2 weeks · target ₹1,900 · Expired
- BUY Ajanta Pharma8 Sept 2026 · ~2 weeks · target ₹3,825 · SL hit

